Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Beta-Blocker Administration in Patients With ST Segment Elevation Myocardial Infraction and SCAI B Status

NCT06967194 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT06967194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06967194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Beta-Blocker Administration in Patients With ST Segment Elevation Myocardial Infraction and SCAI B Status
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 21, 2025
Completion date
June 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock post myocardial infarction, st segment elevation myocardial infarction (stemi)